MYRIAD GENETICS, INC. Proceeds from Sale of Productive Assets
MYRIAD GENETICS, INC. (MYGN) reported Proceeds from Sale of Productive Assets of $0 for the 9-month period ending 2022-09-30, per its 10-Q filed 2022-11-02.
Discontinued › Cash Flow › Investing Activities
us-gaap:ProceedsFromSaleOfProductiveAssets · last filed 2022-11-02
- MYRIAD GENETICS, INC. proceeds from sale of productive assets for the quarter ending 2022-09-30 was $0.00, a 100.00% decline year-over-year.
- MYRIAD GENETICS, INC. proceeds from sale of productive assets for the quarter ending 2021-09-30 was $346.60M.
| Period end | Proceeds from Sale of Productive Assets 3 month | Proceeds from Sale of Productive Assets 6 month | Proceeds from Sale of Productive Assets 9 month |
|---|---|---|---|
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02 | $0.00 10-Q · filed 2022-11-02 | |
| 2022-06-30 | $0.00 10-Q · filed 2022-08-05 | ||
| 2021-09-30 | $346.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02 | $379.10M 10-Q · filed 2022-11-02 | |
| 2021-06-30 | $32.50M 10-Q · filed 2022-08-05 | ||
| 2020-06-30 | $0.00 10-Q · filed 2021-08-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |